Advertisement

Topics

GSK selects third oncology target in discovery partnership with Immunocore

19:00 EDT 3 Jul 2017 | Pharmaceutical Technology

UK-based firm GlaxoSmithKline (GSK) has selected a third target as part of its ongoing oncology discovery partnership with Immunocore for multiple novel targets not addressable with antibody-based technologies.

Original Article: GSK selects third oncology target in discovery partnership with Immunocore

NEXT ARTICLE

More From BioPortfolio on "GSK selects third oncology target in discovery partnership with Immunocore"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...